How can Pharma & smart technology help fight the pandemic

1
How can Pharma smart technology help fight the
pandemic
2
Introduction We are in the middle of a global
humanitarian crisis. Global issues like the
COVID-19 pandemic necessitates a strong and
collaborative fight worldwide. As the pandemic
poses one of the greatest challenges to the
humankind, while weakening the healthcare
systems, it is becoming increasingly important to
address and resolve the issue quickly and
responsibly. There are over 100 vaccine
candidates in the landscape of COVID-19 vaccine
RD and more than three dozen vaccines are under
development. It is expected that a vaccine will
be available by early 2021. However, with the
continuous daily increase in the number of cases,
the vaccine is needed much earlier. In the
current circumstances, the drug regulatory
authorities are also offering relaxations in
their otherwise tight protocols. The U.S. Food
and Drug Administration (FDA) recently released
an Emergency Use Authorization (EUA) for
hydroxychloroquine and chloroquine drugs, which
are used in Malaria and may be used as a
potential therapy against the COVID-19 disease.
3

Artificial Intelligence redefining the Pharma
industry AI-driven solutions, by taking over the
time-consuming labor-intensive processes in a
drug development journey, can help the
pharmaceuticals companies to shorten the time
required to bring a drug to the market. With the
help of machine learning and deep learning
algorithms, Artificial Intelligence can perform
thorough analysis of huge datasets and extensive
review of the available scientific literature.
It can enhance the RD activities such as
design and identification of new molecules,
discovery validation of target based drugs. By
doing so, AI-based pharmaceutical software can
reduce the timeline for trials, approvals, and
release. Further, AI can also help improve the
production processes by facilitating quality
control, design, predictive maintenance, waste
reduction, and reusability. This results in
faster production and efficient outcomes, while
minimizing the possibilities of errors. In
COVID-19 vaccine development process, AI ML can
sift through, analyze, and offer insights gained
through the vast data available on the
SARS-CoV-2, COVID-19, and the coronavirus group
to help pharma companies identify the best
potential treatment for the disease.
4
  Smart automation enabling remote RD Over
the past three months, majority of pharma
companies have mobilized their employees to
remote working conditions. In such a scenario,
automation helps them continue the essential
processes unobstructed. Automation in drug
discovery not only improves the reliability of
the entire process by minimizing manual errors,
but also augments the throughput and enhances the
ability to reproduce. Automation, integrated with
AI, can be significantly helpful in conducting
end-to-end multi-step chemical synthesis of drugs
even in the absence of a manual resource.
Although AI and automation together can bring a
range of benefits to the table, they cannot
eliminate the need for the analytical skills and
expertise of the trained scientists. As the
pharma industry is looking to accelerate the
COVID-19 vaccine development, and scale the
production once the viable drug is found, they
need to employ the three-way solution involving
AI, automation, and expert scientists.   Read
Full Blog at https//www.cigniti.com/blog/pharma-
technology-software-testing-services/

5